Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: Relevance to ischemic heart disease

Free Radical Biology and Medicine

Volumn 25, Issue 4-5, 1998, Pages 404-433

  Grisham, Matthew B ^a   Granger, D Neil ^a   Lefer, David J ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Adhesion; Ischemia; Neutrophils; Nitric oxide; Oxidants; Peroxynitrite; Superoxide

Indexed keywords

CELL ADHESION MOLECULE; EDETATE IRON; FERRYLMYOGLOBIN; HYDROGEN PEROXIDE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROGEN DERIVATIVE; OXYGEN; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR;

CELL INTERACTION; CELL MIGRATION; ENDOTHELIUM CELL; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE ADHERENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 0032171599     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00094-X     Document Type: Article

References (211)

1. Granger D.N., Korthuis R.J. Physiologic mechanisms of postischemic tissue injury. Annu. Rev. Physiol. 57:1995;311-332.
2. Granger D.N., Schmid-Schoenbein G. Physiology and pathophysiology of leukocyte adhesion. 1995;Oxford University Press, New York.
3. Kurose I., Wolf R., Grisham M.B., Granger D.N. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ. Res. 74:1994;376-382.
4. Gaboury J., Woodman R.C., Granger D.N., Reinhardt P., Kubes P. Nitric oxide prevents leukocyte adherence Role of superoxide . Am. J. Physiol. 265:1993;H862-H867.
5. Kubes P., Suzuki M., Granger D.N. Nitric oxide An endogenous modulator of leukocyte adhesion . Proc. Natl. Acad. Sci. USA. 88:1991;4651-4655.
6. Kubes P., Granger D.N. Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262:1992;H611-H615.
7. Wink D.A., Grisham M.B., Mitchell J.B., Ford P.C. Direct and indirect effects of nitric oxide in chemical reactions relevant to biology. Methods Enzymol. 268:1996;12-30.
8. Ford P.C., Wink D.A., Stanbury D.M. Autooxidation kinetics of aqueous nitric oxide. FEBS Lett. 326:1993;1-3.
9. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine. 1989;210-211 Clarendon Press, Oxford, UK.
10. Grisham M.B. Reactive metabolites of oxygen and nitrogen in biology and medicine. 1992;R. G. Landes, Austin, TX.
11. Wink D.A., Wink C.B., Nims R.W., Ford P.C. Oxidizing intermediates generated inthe Fenton reagent Kinetic arguments against the intermediacy of the hydroxyl radical . Environ. Health Perspect. 102:(Suppl 3):1994;11-15.
12. Granger D.N. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am. J. Physiol. 255:1988;H1269-H1275.
13. Kanner J., Harel S., Granit R. Nitric oxide as an antioxidant. Arch. Biochem. Biophys. 289:1991;130-136.
14. Miles A.M., Bohle D.S., Glassbrenner P.A., Hansert B., Wink D.A., Grisham M.B. Modulation of superoxide-dependent oxidation of hydroxylation reactions by nitric oxide. J. Biol. Chem. 271:1996;40-47.
15. Grisham M.B., Everse J. Prooxidant activity of hemoglobin and myoglobin. Everse J., Evers K.E., Grisham M.B. Peroxidases in chemistry and biology I. 1991;335-344 Wiley, New York.
16. 2-dependent arachidonic acid peroxidation. J. Free Radic. Biol. Med. 1:1985;227.
17. Yamada T., Volkmer C., Grisham M.B. The effects of sulfasalazine metabolites on hemoglobin-catalyzed lipid peroxidation. Free Radic. Biol. Med. 10:1991;41-49.
18. Wink D.A., Hanbauer I., Laval F., Cook J.A., Krishna M.C., Mitchell J.B. Nitric oxide protects against the cytotoxic effects of reactive oxygen species. Ann. NY Acad. Sci. 738:1994;265-278.
19. Gorbunov N.V., Osipov A.N., Day B.W., Zayas-Rivera B., Kagan V.E., Elsayed N.M. Reduction of ferrylmyoglobin and ferrylhemoglobin by nitric oxide A protective mechanism against ferryl hemoprotein-induced oxidations . Biochemistry. 34:1995;6689-6699.
20. Jourd'heuil D., Mills L., Miles A.M., Grisham M.B. Effect of nitric oxide on hemoprotein-catalyzed oxidative reactions. Nitric Oxide: Biology and Chemistry. 2:1998;37-44.
21. Hebbel R.P., Eaton J.W., Balasingam M., Steinberg M.H. Spontaneous oxygen radical generation by sickle erythrocytes. J. Clin. Invest. 70:1982;1253.
22. Paller M.S. Hemoglobin and myoglobin-induced acute renal failure in rats Role of iron in nephrotoxicity . Am. J. Physiol. 255:1988;F539-F544.
23. Wallace J.L., Rioux K.P., McKnight G.W., Carter L., Jourd'heuil D., Meddings J., Zimmerman B.J., Granger D.N., Grisham M.B. Hemoprotein-dependent production of a neutrophil activating factor from arachidonic acid. Am. J. Physiol. 263:(5 pt. 2):1992;H1546-H1553.
24. Radomski N.W., Palmer R.M.J., Moncada S. An arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA. 87:1990;5193-5197.
25. May G.R., Crook P., Moore P.K., Page C.P. The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation with the pulmonary circulation of the rabbit. Br. J. Pharmacol. 102:1991;759-763.
26. Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA. 90:1993;7240-7244.
27. Salvemini D., Seibert K., Masferrrer J.L., Misko T.P., Currie M.P., Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J. Clin. Invest. 93:1994;1940-1947.
28. McDaniel M.L., Kwon G., Hill J.R., Marshall C.A., Corbett J.A. Cytokines and nitric oxide in islet inflammation and diabetes. Proc. Soc. Exp. Biol. Med. 211:1996;24-31.
29. Corbett J.A., Kwon G., Turk J., McDaniel M.L. IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans Activation of cyclooxygenase by nitric oxide . Biochemistry. 32:1993;13767-13770.
30. Sautebin L., Di Rosa M. Nitric oxide modulates prostacyclin biosynthesis in the lung of endotoxin-treated rats. Eur. J. Pharmacol. 262:1994;193-196.
31. Laszlo F., Whittle B.J., Moncada S. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxemia. Br. J. Pharmacol. 113:1994;1131-1136.
32. Davidge S.T., Baker P.N., Laughlin M.K., Roberts J.M. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ. Res. 77:1995;274-283.
33. Inoue T., Fukuo K., Morimot O.S., Koh E., Ogihara T. Nitric oxide mediates interleukin-1 induced prostaglandin E2 production by vascular smooth muscle cells. Biochem. Biophys. Res. Comm. 194:1993;420-424.
34. 2 isomerase activity by PDGF Involvement of nitric oxide . Arch. Biochem. Biophys. 312:1994;240-243.
35. Hempel S.L., Monick M.M., He B., Yano T., Hunninghake G.W. Synthesis of prostaglandin H synthase-2 by human alveolar macrophages in response to lipopolysaccharide is inhibited by decreased cell oxidant tone. J. Biol. Chem. 269:1994;32979-32984.
36. Kanner J., Harel S., Granit R. Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxgenase and hemoglobin. Lipids. 27:1992;46-49.
37. Maccarrone M., Corasaniti M.T., Tiziana M., Guerrieri P., Nistico G., Alessandro F. Nitric oxide-donor compounds inhibit lipoxygenase activity. Biochem. Biophys. Res. Comm. 219:1996;128-133.
38. Nakatsuka M., Osawa Y. Selective inhibition of the 12-lipoxygenase pathway or arachidonic acid metabolism by L-arginine or sodium nitroprusside in intact human platelets. Biochem. Biophys. Res. Comm. 200:1994;1630-1634.
39. Rubbo H., Parthasarathy S., Barnes S., Kirk M., Kalyanaraman B., Freeman B.A. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation Termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives . Arch. Biochem. Biophys. 324:1995;15-25.
40. Padmaja S., Huie R.E. The reaction of nitric oxide with organic peroxyl radicals. Biochem. Biophys. Res. Comm. 195:1993;539-544.
41. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S., Kirk M., Freeman B.A. Nitric oxide regulation of superoxide and peroxynitrite dependent lipid peroxidation Formation of novel nitrogen containing oxidized lipid derivatives . J. Biol. Chem. 269:1994;26066-26075.
42. Struck A.T., Hogg N., Thomas J.P., Kalyanaraman B. Nitric oxide donor compounds inhibit the toxicity of oxidized low-density lipoprotein to endothelial cells. FEBS Lett. 361:1995;291-294.
43. Hogg N., Struck A., Goss S.P., Santanam N., Joseph J., Parthasarathy S., Kalyanaraman B. Inhibition of macrophage-dependent low density lipoprotein oxidation by nitric oxide donors. J. Lipid Res. 36:1995;1756-1762.
44. Cayatte A.J., Palacino J.J., Horten K., Cohen R.A. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Artherioscler. Thromb. 14:1994;753-759.
45. 2+-induced LDL oxidation by nitric oxide A study using donors with different half-time of NO release . Biochem. Biophys. Res. Comm. 220:1996;306-309.
46. Hayashi K., Noguchi N., Niki E. Action of nitric oxide as an antioxidant against oxidation of soybean posphatidycholine liposomal membranes. FEBS Lett. 370:1995;37-40.
47. Laskey R.E., Mathews W.R. Nitric oxide inhibits peroxynitrite-induced production of hydroxyeicosatetraenoic acids and F2-isoprostanes in phosphatidylcholine liposomes. Arch. Biochem. Biophys. 330:1996;193-198.
48. Wink D.A., Cook J., Pacelli R., DeGraff W., Gamson J., Liebmann J., Krishna M., Mitchell J.B. Effect of various nitric oxide-donor agents on peroxide mediated toxicity A direct correlation between nitric oxide formation and protection . Arch. Biochem. Biophys. 331:1996;241-248.
49. 2 reaction . Chem. Res. Toxicol. 6:1993;23-27.
50. Grisham M.B., Miles A.M. Effects of aminosalicylates and immunosuppressive agents on nitric oxide dependent N-nitrosation reactions. Biochem. Pharmacol. 47:1994;1897-1902.
51. Stamler J.S. Redox signaling Nitrosylation and related target interactions of nitric oxide . Cell. 78:1994;931-936.
52. Ignarro L.J., Edwards J.C., Gruetter D.Y., Barry B.K., Gruetter C.A. Possible involvement of S-nitrosothiols activation of guanylate cyalose nitroso compounds. FEBS Lett. 110:1980;275-278.
53. Ignarro L.J., Barry B.K., Gruetter D.Y., Edwards J.C., Ohlstein E.H., Gruetter C.A., Baricos W.H. Guanylate cyalose activation by nitroprusside and nitroguanidine is related to formation of S-nitrosothiol intermediates. Biochem. Biophys. Res. Comm. 94:1980;93-100.
54. Ignarro L.J. Endothelium-derived nitric oxide Pharmacology and relationship to the actions of organic esters . Pharm. Res. 6:1989;651-659.
55. Myers P.R., Minor R.L., Guerra R., Bates J.N., Harrison D.G. Vasorelaxant properties of the endothelium derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature. 345:1990;161-163.
56. Stamler J.S., Jaraki O., Osbourne J., Simon D.I., Keaney J., Vita J., Singel D., Valeri R., Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA. 89:1992;7674-7677.
57. Gaston B., Reilly J., Drazen J.M., Fackler J., Ramdev P., Arnelle D., Mullins M.E., Sugarbaker D.J., Chee C., Singel D.J., Loscalzo J., Stamler J.S. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc. Natl. Acad. Sci. USA. 90:1993;10957-10961.
58. Schwartz B., Harlan J. Neutrophil membrane sulfhydryl groups are involved in stimulated neutrophil adherence to endothelium. J. Leuk. Biol. 45:1989;177-182.
59. Wink D.A., Cook J.A., Kim S.Y., Vodovotz Y., Pacelli R., Krishna M.C., Russo A., Mitchell J.B., Jourd'heuil D., Miles A.M., Grisham M.B. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived intermediates. J. Biol. Chem. 272:1997;11147-11151.
60. Jourd'heuil D., Mai C.T., Laroux F.S., Wink D.A., Grisham M.B. The reaction of S-nitrosoglutathione with superoxide. Biochem. Biophys. Res. Comm. 244:1998;525-530.
61. 2 reaction . Chem. Res. Toxicol. 7:1994;519-525.
62. Skaleric U., Allen J.B., Smith P.D., Mergenhagen S.E., Wahl S.M. Inhibitors of reactive oxygen intermediates suppress bacterial cell wall-induced arthritis. J. Immunol. 147:1991;2559-2564.
63. Clark D.A., Fornabaio D.M., McNeill H., Mullane K.M., Caravella S.J., Miller M.J.S. Contribution of oxygen-2Dderived free radicals to experimental necrotizing enterocolitis. Am. J. Pathol. 130:1988;537-542.
64. Johnson K.J., Ward P.A. Role of oxygen metabolites in immune complex injury of lung. J. Immunol. 126:1981;2365-2369.
65. McCartney-Francis N., Allen J.B., Mizel D.E., Albina J.E., Xie Q., Nathan C.F., Wahl S.M. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178:1993;749-754.
66. Grisham M.B., Specian R.D., Zimmerman T.E. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J. Pharm. Exp. Ther. 271:1994;1114-1121.
67. Mulligan M.S., Moncada S., Ward P.A. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br. J. Pharmacol. 107:1992;1159-1162.
68. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite Implication for endothelial injury from nitric oxide and superoxide . Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
69. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls The cytotoxic potential of superoxide and nitric oxide . J. Biol. Chem. 266:1991;4244-4250.
70. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S., Kirk M., Freeman B.A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation Formation of novel nitrogen-containing oxidized lipid derivatives . J. Biol. Chem. 269:1994;26066-26075.
71. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite-induced membrane lipid peroxidation The cytotoxic potential of superoxide and nitric oxide . Arch. Biochem. Biophys. 288:1991;481-487.
72. King P.A., Jamison E., Strahs D., Anderson V.E., Brenowitz M. "Footprinting" proteins on DNA with peroxynitrous acid. Nucleic Acids Res. 21:1993;2473-2478.
73. Zhu L., Gunn C., Beckman J.S. Bactericidal activity of peroxynitrite. Arch. Biochem. Biophys. 298:1992;452-457.
74. Kooy N.W., Royall J.A. Agonist-induced peroxynitrite production from endothelial cells. Arch. Biochem. Biophys. 310:1994;352-359.
75. Koppenol W.H., Moreno J.J., Pryor W.A., Ischiropoulus H., Beckman J.S. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol. 5:1992;834-842.
76. Koppenol W.H., Kissner R., Beckman J.S. Synthesis of peroxynitrite to go with the flow or on solid ground . Meth. Enz. 269:1996;296-301.
77. Huie R.E., Padmaja S. The reaction of NO with superoxide. Free Radic. Res. Comm. 18:1993;195-199.
78. Wink D.A., Grisham M.B., Miles A.M., Nims R.W., Krishna M.C., Pacelli R., Teague D., Poore C.M.B., Cook J.C. Methods for determination of selectivity of reactive nitrogen oxide species for various substrates. Methods Enzymol. 268:1996;120-129.
79. Nikano, M.; Kimura, H.; Hara, M.; Kuroiwa, M.; Kato, M.; Totsune, K.; Yoshikawa, T. A highly sensitive method for determining both Mn- and Cu-Zn superoxide dismutase activities in tissue and blood cells. Anal. Biochem. 187:277-180; 1990.
80. Weinberg J.B., Misukonis M.A., Shami P.J., Mason S.N., Sauls D.L., Dittman W.A., Wood E.R., Smith G.K., McDonald B., Bachus K.E., Haney A.F., Granger D.L. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS) Analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages . Blood. 86:1995;1184-1195.
81. Miles A.M., Owens M.W., Milligan S., Johnson G.G., Fields J.Z., Ing T.S., Kottapoalli V., Keshavarzian A., Grisham M.B. Nitric oxide synthase in circulating vs. extravasated polymorphonuclear leukocytes. J. Leuk. Biol. 58:1995;616-622.
82. Granger D.N., Kubes P. The microcirculation and inflammation Modulation of leukocyte-endothelial cell adhesion . J. Leuk. Biol. 55:1994;662-675.
83. McEver R.P. Selectins Novel receptors that mediate leukocyte adhesion during inflammation . Thromb. Haemost. 65:1991;223-228.
84. Eppihimer M.J., Wolitzky B., Anderson D.C., Labow M.A., Granger D.N. Heterogeneity of expression of E- and P-selectins in vivo. Circ. Res. 79:1996;560.
85. Kurose I., Anderson D.C., Paulson J.C., Todd J.C., Miyasaka M., Granger D.N. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ. Res. 74:1994;336-343.
86. Henninger D.D., Liao L., Granger D.N. Nitric oxide as a modulator of leukocyte function in atherosclerosis. Kubes P. Nitric oxide A modulator of cell-cell interactions in the microcirculation . 1995;127-145 Springer-Verlag, New York.
87. Kurose I., Granger D.N., Evans D.J., Evans D.G., Graham D.Y., Miyasaka M., Anderson D.C., Wolf R.E., Cepinskas G., Kvietys P.R. Helicobacter pylori-induced microvascular protein leakage in rats Role of neutrophils, mast cells, and platelets . Gastroenterology. 1074:1994;70-79.
88. Korthuis R.J., Anderson D.C., Granger D.N. Role of neutrophil-endothelial cell adhesion in inflammatory disorders. J. Crit. Care. 9:1994;47-71.
89. Panes J., Perry M.A., Anderson D.C., Manning A., Leone B., Cepinskas G., Rosenbloom C.L., Miyasaka M., Kvietys P.R., Granger D.N. Regional differences in constitutive and induced ICAM-1 expression in vivo. Am. J. Physiol. 269:1995;H1955.
90. Sligh J.E., Ballantyne C.M., Rich S.S., Hawkins H.K., Smith C.W., Bradley A., Beaudet A.L. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule-1. Proc Natl Acad Sci. USA. 90:1993;852.
91. Gearing A.J.H., Newman W. Circulating adhesion molecules in disease. Immunol. Today. 14:1993;506-512.
92. Henninger, D. D.; Panes, J.; Eppihimer, M.; Russell, J.; Gerritsen, M.; Anderson, D. C; Granger, D. N. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J. Immunol. (In press); 1997.
93. Gallin J.I. Degranulating stimuli decrease the negative surface charge and increase the adhesiveness of human neutrophils. J. Clin. Invest. 65:1980;298-306.
94. Asako H., Kurose I., Wolf R.E., Granger D.N. Mechanisms of lactoferrin-induced leukocyte-endothelial cell adhesion in postcapillary venules. Microcirculation. 1:1994;27-34.
95. Gaboury J.P., Kubes P. Endogenous antiadhesive molecules. Granger D.N., Schmid-Schoenbein G. Physiology and pathophysiology of leukocyte adhesion. 1994;241-260 Oxford University Press, New York.
96. Grisham M.B., Hernandez L.A., Granger D.N. Adenosine inhibits ischemia/reperfusion-induced leukocyte adherence and extravasation. Am. J. Physiol. 257:1989;H1334-H1339.
97. Asako H., Wolf R., Granger D.N. Leukocyte adherence in rat mesenteric venules Effects of adenosine and methotrexate . Gastroenterology. 104:1993;31-37.
98. Asako H., Kubes P., Wallace J.L., Gaginella T., Wolf R.E., Granger D.N. Indomethacin-induced leukocyte adhesion in mesenteric venules Role of lipoxygenase products . Am. J. Physiol. 262:1992;G903-G908.
99. Inauen W., Payne D.K., Kvietys P.R., Granger D.N. Hypoxia/reoxygenation increases the permeability of endothelial cell monolayers Role of oxygen radicals . Free Radic. Biol. Med. 9:1990;219-223.
100. Yoshida N., Granger D.N., Anderson D.C., Rothlein R., Lane C., Kvietys P.R. Anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Am. J. Physiol. 262:1992;H1891-H1898.
101. Inauen W., Granger D.N., Meininger C.J., Schelling M.E., Granger H.J., Kvietys P.R. An in vitro model of ischemia/reperfusion-induced microvascular injury. Am. J. Physiol. 259:1990;G134-G139.
102. Inauen W., Granger D.N., Meininger C.J., Schelling M.E., Granger H.J., Kvietys P.R. Anoxia-reoxygenation-induced, neutrophil-mediated endothelial cell injury Role of elastase . Am. J. Physiol. 259:1990;H925-H931.
103. Milhoan K.A., Lane T.A., Bloor C.M. Hypoxia induces endothelial cells to increase their adherence for neutrophils Role of PAF . Am. J. Physiol. 263:1992;H956-H962.
104. Michiels C., Arnould T., Houbion A., Remacle J. Human umbilical vein endothelial cells submitted to hypoxia-reoxygenation in vitro Implication of free radicals, xanthine oxidase, and energy deficiency . J. Cell Physiol. 153:1992;53-61.
105. Wiles M.E., Hechtman H.B., Morel N.M.L., Shepro D. Hypoxia reoxygenation-induced injury of cultured pulmonary microvessel endothelial cells. J. Leuk. Biol. 53:1993;490-497.
106. Palluy O., Morliere L., Gris J.C., Bonne C., Modat G. Hypoxia/reoxygenation stimulates endothelium to promote neutrophil adhesion. Free Radic. Biol. Med. 13:1992;21-30.
107. Arnould T., Michiels C., Remacle J. Increased PMN adherence on endothelial cells after hypoxia Involvement of PAF, CD18/CD11b, and ICAM-1 . Am. J. Physiol. 264:1993;C1102-C1110.
108. Lum H., Barr D.A., Shaffer J.R., Gordon R.J., Ezrin A.M., Malik A.B. Reoxygenation of endothelial cells increases permeability by oxidant-dependent mechanisms. Circ. Res. 70:1992;991-998.
109. Kurose I., Argenbright L.W., Anderson D.C., Tolley J., Miyasaka M., Harris N., Granger D.N. Reperfusion-induced leukocyte adhesion and vascular protein leakage in normal and hypercholeserolemic rats. Am. J. Physiol. 273:(2 Pt. 2):1997;H854-H869.
110. Suzuki M., Asako H., Kubes P., Jennings S., Grisham M.B., Granger D.N. Neutrophil-derived oxidants promote leukocyte adherence in postcapillary venules. Microvasc. Res. 42:1991;125-138.
111. Bazzoni G., Dejana E., Del Maschio A. Platelet-neutrophil interactions, possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica. 76:1991;491-499.
112. Golino P., Maroko P.R., Carew T.E. Efficacy of platelet depletion in counteracting the detrimental effect of acute hypercholesterolemia on infarct size and the no-reflow phenomenon in rabbits undergoing coronary artery occlusion-reperfusion. Circulation. 76:1987;173-180.
113. Kurose I., Kubes P., Wolf R., Anderson D.C., Paulson J., Miyasaka M., Granger D.N. Inhibition of nitric oxide production Mechanisms of vascular albumin leakage . Circ. Res. 73:1993;164-171.
114. Harlan J.M., Liu D.Y. Adhesion Its role in inflammatory disease . 1992;W. H. Freeman, New York.
115. Zimmerman G.A., Prescott S.M., McIntyre T.M. Platelet-activating factor A fluid-phase and cell-associated mediator of inflammation . Gallin J.I., Goldstein I.M., Snyderman R. Inflammation: Basic principles and clinical correlates, second ed. 1992;149-176 Raven Press, New York.
116. McIntyre T.M., Patel K.D., Zimmerman G.A., Prescott S.M. Oxygen radical-mediated leukocyte adherence. Granger D.N., Schmid-Schönbein G.W. Physiology and pathophysiology of leukocyte adhesion. 1995;261-277 Oxford University Press, New York.
117. Mozes T., Braquet P., Filip J. Platelet-activating factor An endogenous mediator of mesenteric ischemia-reperfusion induced shock . Am. J. Physiol. 257:1989;R872-R877.
118. Kubes P., Ibbotson G., Russel J., Wallace J.L., Granger D.N. Role of platelet activating factor in ischemia/reperfusion-induced leukocyte adherence. Am. J. Physiol. 359:1990;G300-G305.
119. Kravchenko V.V., Pan Z., Han J., Hebert J., Ulevitch R.J., Ye R.D. Platelet-activating factor induces NF-MB activation through a G protein-coupled pathway. J. Biol. Chem. 270:1995;14928-14934.
120. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules NF-κB and cytokine-inducible enhancers . FASEB J. 9:1995;899-909.
121. Manning A.M., Anderson D.C. Transcription factor NF-κB An emerging regulator of inflammation . Annu. Rep. Med. Chem. 28:1994;235-244.
122. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:1994;405-455.
123. Read M.A., Neish A.S., Luscinskas F.W., Palombella V.J., Maniatis T., Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity. 2:1995;493-506.
124. Sappey C., Boelaert J.R., Legrand-Poels S., Grady R.W., Piette J. NF-κB transcription factor activation by hydrogen peroxide can be decreased by 2,3-dihydroxybenzoic acid and its ethyl ester derivative. Arch. Biochem. Biophys. 321:1995;263-270.
125. Peng H.B., Libby P., Liao J.K. Induciton and stabilization of IκBx by nitric oxide mediates inhibition of NFκB. J. Biol. Chem. 270:1995;14214-14219.
126. Patel K.D., Zimmerman G.A., Prescott S.M., McEver R.P., McIntyre T.M. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J. Cell Biol. 112:1991;749-759.
127. Lefer A.M. Leukotrienes as mediators of ischemia and shock. Biochem. Pharmacol. 35:1986;123-127.
128. 4 in granulocyte infiltration into the postischemic feline intestine. Gastroenterology. 99:1990;1-6.
129. Lam B.K., Austen K.F. Leukotrienes Biosynthesis, release and actions . Gallin J.I., Goldstein I.M., Snyderman R. Inflammation Basic principles and clinical correlates, second ed . 1992;139-147 Raven Press, New York.
130. Mangino M.J., Anderson C.B., Murphy M.K., Brunt E., Turk J. Mucosal arachidonate metabolism and intestinal ischemia-reperfusion injury. Am. J. Physiol. 257:1989;G299-G307.
131. Baggiolini M., Dewald B., Walz A. Interleukin-8 and related chemotactic cytokines. Gallin J.I., Goldstein I.M., Snyderman R. Inflammation Basic principles and clinical correlates, second ed . 1992;247-263 Raven Press, New York.
132. Karakurum M., Shreeniwas R., Chen J., Pinsky D., Yan S.-D., Anderson M., Sunouchi K., Major J., Hamilton T., Kuwabara K., Rot A., Nowygrod R., Stern D. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Invest. 93:1994;1564-1570.
133. DeForge L.E., Preston A.M., Takeuchi E., Kenney J., Boxer L.A., Remick D.G. Regulation of interleukin-8 gene expression by oxidant stress. J. Biol. Chem. 268:1993;25568-25576.
134. DeForge L.E., Fantone J.C., Kenney J.S., Remick D.G. Oxygen radical scavengers selectively inhibit interleukin-8 production in human whole blood. J. Clin. Invest. 90:1992;2123-2129.
135. De Caterina R., Libby P., Peng H., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A. Jr, Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines . J. Clin. Invest. 96:1995;60-68.
136. Liao L., Granger D.N. Modulation of oxidized low-density lipoprotein-induced microvascular dysfunction by nitric oxide. Am. J. Physiol. 268:1995;H1643-H1650.
137. Kubes P., Kurose I., Granger D.N. Nitric oxide donors prevent integrin-induced leukocyte adhesion, but not P-selectin dependent rolling, in postischemic venules. Am. J. Physiol. 267:1994;H931-H937.
138. Kubes P. Nitric oxide modulates leukocyte funciton in ischemia/reperfusion. Kubes P. Nitric oxide A modulation of cell-cell interactions in the microcirculation . 1995;101-126 R. G. Landes, Austin, TX.
139. Christodoulou D., Kudo S., Cook J.A., Krishna M.C., Miles A., Grisham M.B., Murugesan R., Ford P.C., Wink D.A. Electrochemical methods for detection of nitric oxide. Methods Enzymol. 268:1996;69-83.
140. Suzuki M., Inauen W., Kvietys P.R., Grisham M.B., Meininger C.J., Schelling M., Granger H.J., Granger D.N. Superoxide mediates reperfusion-induced leukocyte-endothelial cell interactions. Am. J. Physiol. 257:1989;H1740-H1745.
141. Kubes P., Kanwar S., Niu X.-F., Gaboury J.P. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 7:1993;1293-1299.
142. Ma X., Weyrich A.S., Lefer D.J., Lefer A.M. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ. Res. 72:1993;403-412.
143. Arndt H., Russell J.B., Kurose I., Kubes P., Granger D.N. Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology. 105:1993;675-680.
144. Kurose I., Wolf R., Grisham M.B., Aw T.Y., Specian R.D., Granger D.N. Microvascular responses to inhibition of nitric oxide production Role of active oxidants . Circ. Res. 76:1995;30-39.
145. Suematsu M., Tamatani T., Delano F.A., Miyasaka M., Forrest M., Suzuki H., Schmid-Schönbein G.W. Microvascular oxidative stress preceding leukocyte activation elicited by in vivo nitric oxide suppression. Heart Circ. Physiol. 35:1994;H2410-H2415.
146. Kurose I., Argenbright L.W., Wolf R., Lianxi L., Granger D.N. Ischemia/reperfusion-induced microvascular dysfunction Rose of oxidants and lipid mediators . Am. J. Physiol. 272:(6 Pt. 2):1997;H2976-H2982.
147. Kanwar S., Tepperman B.L., Payne D., Sutherland L.R., Kubes P. Time course of nitric oxide production and epithelial dysfunction during ischemia/reperfusion of the feline small intestine. Circ. Shock. 42:1994;135-140.
148. 2 inhibition prevents mucosal damage associated with small intestinal ischemia in rats. Gut. 29:1988;489-494.
149. Niu X.-F., Smith C.W., Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesivity for neutrophils. Circ. Res. 74:1994;1133-1140.
150. Niu X.-F., Ibbotson G., Kubes K. A balance between nitric oxide and oxidants regulates mast cell-dependent neutrophil-endothelial cell interactions. Circ. Res. 79:1996;992-999.
151. Kubes P. Nitric oxide-induced microvascular permeability alterations A regulatory role for cGMP . Am. J. Physiol. 265:1993;H1910-H1915.
152. Kubes P., Grisham M.B., Barrowman J.A., Gaginella T., Granger D.N. Leukocyte-induced vascular protein leakage in cat mesentery. Am. J. Physiol. 261:1991;H1872-H1879.
153. Beckman J.S., Crow J.P. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21:1993;330-334.
154. 4-induced increases in microvascular transport. Am. J. Physiol. 265:1993;H409-H414.
155. Mayhan, W. G. Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5′-diphosphate and bradykinin. Inflammation 16:87-85; 1992.
156. Yuan Y., Granger H.J., Zawieja D.C., Chilian W.M. Flow modulates coronary venular permeability by a nitric oxide-related mechanism. Am. J. Physiol. 263:1992;H641-H646.
157. Mulligan M.S., Hevel J.M., Marletta M.A., Ward P.A. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc. Natl. Acad. Sci. USA. 88:1991;6338-6342.
158. Seekamp A., Mulligan M.S., Till G.O., Ward P.A. Requirements for neutrophil products and L-arginine in ischemia-2Dreperfusion injury. Am. J. Pathol. 142:1993;1-10.
159. Matheis G., Sherman M.P., Buckberg G.D., Haybron D.M., Young H.H., Ignarro L.J. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am. J. Physiol. 262:1992;H616-H620.
160. Sommers H.M., Jennings R.B. Experimental acute myocardial infarction Histological and histochemical studies of early myocardial infarcts induced by temporary or permanent occlusion of a coronary artery . Lab. Invest. 13:1964;1491-1503.
161. Reimer K.A., Lowe J.E., Rasmussen M.M., Jennings R.B. The wavefront phenomenon of ischemic cell death I. Myocardial infarct size vs. duration of coronary artery occlusion in dogs . Circulation. 56:1977;786-794.
162. Sheehan F.H., Braunwald E., Canner P., Dodge H.T., Gore J., Van Natta P., Passamani E.R., Williams D.O., Zaret B. The effects of intravenous thrombolytic therapy on left ventricular function A report on t-PA and streptokinase from the TIMI Phase I trial . Circulation. 75:1987;817-829.
163. Koren G., Weiss A.T., Hasin Y., Appelbaum D., Welber S., Rozenman Y., Lotan C., Mosseri M., Sapoznikov D., Luria M.H., Gotsman M.S. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N. Engl. J. Med. 313:1985;1384-1389.
164. Forman, M. B.; Virmani, R.; Puett, D. W. Mechanisms and therapy of myocardial reperfusion injury. Circulation 81(Suppl IV):69-78; 1990.
165. Braunwald E., Kloner R.A. Myocardial reperfusion A double-edged sword? J. Clin. Invest. 76:1985;1713-1719.
166. Mullane K. Neutrophil and endothelial changes in reperfusion injury. Trends Cardiovasc. Pharm. 1:1991;282-289.
167. Simpson P.J., Lucchesi B.R. Free radicals and myocardial ischemia and reperfusion injury. J. Lab. Clin. Med. 110:1987;13-27.
168. Tsao P.S., Aoki N., Lefer D.J., Johnson G., Lefer A.M. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 82:1990;1402-1412.
169. Ma X.-L., Weyrich A.S., Lefer D.J., Lefer A.M. Dimished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ. Res. 72:1993;403-412.
170. Van Benthuysen K.M., McMurtry I.F., Horwitz L.D. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J. Clin. Invest. 79:1987;265-274.
171. 2 inhibitor U-63557 . Am. J. Physiol. 257:1989;H1240-H1246.
172. Ku D.D. Coronary vascular reactivity after acute myocardial ischemia. Science. 218:1982;576-578.
173. Lefer D.J., Nakanishi K., Vinten-Johansen J., Ma X.-L., Lefer A.M. Cardiac venous endothelial dysfunction after myocardial ischemia and reperfusion in dogs. Am. J. Physiol. 263:1992;H850-H856.
174. Zweier J.L., Flaherty J.T., Weisfeldt M.L. Observation of free radical generation in the post-ischemic heart. Proc. Natl. Acad. Sci. USA. 84:1987;1404-1407.
175. Rubanyi G.M., Vanhoutte P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relacing factor. Am. J. Physiol. 250:1986;H822-H827.
176. Hansen P.R. Role of neutrophils in myocardial ischemia and reperfusion. Circulation. 91:1995;1872-1885.
177. Lucchesi B.R. Modulation of leukocyte-mediated myocardial reperfusion injury. Annu. Rev. Physiol. 52:1990;561-576.
178. Ma X.-L., Lefer D.J., Lefer A.M., Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation. 86:1992;937-946.
179. Ma X.-L., Tsao P.S., Lefer A.M. Antibody to CD-18 exerts endothelial and cardioprotective effects in myocardial ischemia and reperfusion. J. Clin. Invest. 88:1991;1237-1243.
180. Weyrich A.S., Ma X.-L., Lefer D.J., Albertine K.H., Lefer A.M. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91:1993;2620-2629.
181. Kramer J.H., Arroyo C.M., Dickens B.F., Weglicki W.B. Spin-trapping evidence that graded myocardial ischemia alters postischemic superoxide production. Free Radic. Biol. Med. 3:1987;153-159.
182. Garlick P.B., Davies M.J., Hearse D.J., Slater T.F. Direct detection of free radicals in reperfused heart using electron spin resonance spectroscopy. Circ. Res. 61:1987;757-760.
183. Zweier J.L., Kuppasamy P., Lutty G.A. Measurement of endothelial cell free radical generation Evidence for a central mechanism of free radical injury in postischemic tissue . Proc. Natl. Acad. Sci. USA. 85:1988;4046-4050.
184. Jolly S.R., Kane W.J., Bailie M.B., Abrams G.D., Lucchesi B.R. Canine myocardial reperfusion injury Its reduction by the combined administration of superoxide dismutase and catalase . Circ. Res. 54:1984;277-285.
185. Ambrosio G., Becker L.C., Hutchins G.M., Weisman H.F., Weisfeldt M.L. Reduction in experimental infarct size by recombinant human superoxide dismutase Insights into the pathophysiology of reperfusion injury . Circulation. 74:1986;1424-1433.
186. Werns S.W., Simpson P.J., Mickelson J.K., Shea M.J., Pitt B., Lucchessi B.R. Sustained limitation by superoxide dismutase of canine myocardial injury due to regional ischemia followed by reperfusion. J. Cardiovasc. Pharmacol. 11:1988;36-44.
187. Naslund U., Haggmark S., Johansson G., Marklund S.L., Reiz S., Oberg A. Superoxide dismutase and catalase reduce infarct size in a porcine myocardial occlusion reperfusion model. J. Mol. Cell. Cardiol. 18:1986;1077-1084.
188. Gallagher K.P., Buda A.J., Pace D., Gerren R.A., Shafler M. Failure of superoxide dismutase and catalase to alter size of infarction in concious dogs after 3 hours of occlusion followed by reperfusion. Circulation. 73:1986;1065-1076.
189. Uraizee A., Reimer K.A., Murray C.E., Jennings R.B. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. Circulation. 75:1987;1237-1248.
190. Nejima J., Knight D.R., Fallon J.T., Uemura N., Manders W.T., Canfield D.R., Cohen M.V., Vatner S.F. Superoxide dismuase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in concious dogs. Circulation. 79:1989;143-153.
191. Shirato C., Miura T., Downey J.M. Superoxide dismutase (single dose) delays rather than prevents necrosis in reperfused rabbit heart. FASEB J. 2:1988;A918.
192. Engler R., Gilpin E. Can superoxide dismutase alter infarct size? Circulation. 79:1989;1137-1142.
193. Johnson, G., III, Tsao, P. S.; Lefer, A. M. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit. Care Med. 19:244-242; 1991.
194. Johnson G. III, Tsao P.S., Lefer A.M. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J. Pharmacol. Exp. Ther. 252:1990;35-41.
195. Siegfried M.R., Carey C., Ma X.-L., Lefer A.M. Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am. J. Physiol. 263:1992;H771-H777.
196. Siegfried M.R., Erhardt J., Rider T., Ma X.-L., Lefer A.M. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J. Pharmacol. Exp. Ther. 260:1992;668-675.
197. Lefer D.J., Nakanishi K., Johnston W.E., Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation. 88:1993;2337-2350.
198. Lefer D.J., Nakanishi K., Vinten-Johansen J. Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion. J. Cardiovasc. Pharmacol. 22:(Suppl. 7):1993;S34-S43.
199. Hasebe N., Shen Y.T., Vatner S.F. Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dog. Circulation. 88:1993;2862-2871.
200. Pinsky D.J., Oz M.C., Koga S. Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J. Clin. Invest. 93:1994;2291-2297.
201. Weyrich A.S., Ma X.-L., Lefer A.M. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation. 86:1992;279-288.
202. Nakanishi K., Vinten-Johansen J., Lefer D.J., Zhao Z., Fowler W.C. III, McGee D.S., Johnston W.E. Intracoronary L-arginine during repefusion improves endothelial function and reduces infarct size. Am. J. Physiol. 263:1992;H1650-H1658.
203. Schulz R., Wamboldt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc. Res. 30:1995;432-439.
204. Mathies G., Sherman M.P., Buckberg G.D., Haybron D.M., Young H.H., Ignarro L.J. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am. J. Physiol. 262:1992;H616-H620.
205. Pabla R., Buda A.J., Flynn D.M., Salzberg D.B., Lefer D.J. Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. Am. J. Physiol. 269:1996;H1113-H1121.
206. Villa L.M., Salas E., Darley-Usmar V.M., Radomski M.W., Moncada S. Peroxynitirite induces both vasodilation and impaired vascular relaxation in the isolated perfused rat heart. Proc. Natl. Acad. Sci. USA. 91:1994;12383-12387.
207. Wu M.N., Pritchard K.A., Kaminski P.M., Fayngersh R.P., Hintze T.H., Wolin M.S. Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxynitrite. Am. J. Physiol. 266:1994;H2108-H2113.
208. Liu S., Beckman J.S., Ku D.D. Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs. J. Pharmacol. Exp. Ther. 68:1994;1114-1121.
209. Ku D.D., Liu S., Dai J. Coronary vascular and antiplatelet effects of peroxynitite in human tissues. Endothelium. 3:1995;309-319.
210. Naseem K.M., Bruckdorfer K.R. Hydrogen peroxide at low concentrations strongly enhances the inhibitory effect of nitric oxide on platelets. Biochem. J. 310:1995;149-153.
211. Moro M.A., Darley-Usmar V.M., Goodwin D.A., Read N.G., Zamora-Pino R., Feelisch M., Radomski M.W., Moncada S. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc. Natl. Acad. Sci. USA. 91:1994;6702-6706.